Seyed Kazem Mirinezhad

Seyed Kazem Mirinezhad

Auto-generated profile, based on publicly available information

Seyed Kazem Mirinezhad

Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2008
Verified
Journal Article
Closed access
MSMohammad H Somi
Mohammad H Somi
SFSara Farhang
Sara Farhang
SMSeyed Kazem Mirinezhad
Seyed Kazem Mirinezhad
SNShahnaz Naghashi
Shahnaz Naghashi
MSMehran Seif-Farshad
Mehran Seif-Farshad
MGMehrad Golzari
Mehrad Golzari

31 July 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
SMSeyed Kazem Mirinezhad
Seyed Kazem Mirinezhad
MSMohammad Hossein Somi
Mohammad Hossein Somi
AJAmir Ghasemi Jangjoo
Amir Ghasemi Jangjoo
FSFarshad Seyednezhad
Farshad Seyednezhad
SDSaeed Dastgiri
Saeed Dastgiri
BNBehnam Nasiri
Behnam Nasiri
Esophageal cancer in Iran is the sixth most common cancer and is particularly important in east Azerbaijan. The aim of this study was to calculate survival rates and define prognostic factors in esophageal cancer patients. In this study, all patients with esophageal cancer registered in the Radiation Therapy Center, during March 2006 to March 2011, were analyzed and followed up for vital status. Data were analyzed using the Kaplan-Meier method and the Cox proportional hazard models. Out of 532 patients, survival information was available for 460, including 205 (44/5%) females and 255 (55/4%) males. The mean age was 65.8±12.2, ranging from 29 to 90 years at the time of diagnosis. 1- , 3- and 5-year survival rates after diagnosis were 55%, 18% and 12%, respectively, with a median survival time of 13.2 ± .7 (CI 95%=11.8-14.6) months. In the univariate analysis, age (P=0/001), education (P=0/001), smoking status (P= 0/001), surgery (P=0/001), tumor differentiation (P=0/003) and tumor stage (P=0/001) were significant prognostic factors. Tumor morphology, sex, place of residence, tumor histology and tumor location did not show any significant effects on the survival rate. In multivariate analysis, age (P=0/003), smoking (P=0/01) and tumor stage (P=0/001) were significant independent predictors of survival. In summary, prognosis of esophageal cancer in North West of Iran is poor. Therefore, reduction in exposure to risk factors and early detection should be emphasized to improve survival.

30 January 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SMSeyed Kazem Mirinezhad
Seyed Kazem Mirinezhad
AJAmir Ghasemi Jangjoo
Amir Ghasemi Jangjoo
FSFarshad Seyednejad
Farshad Seyednejad
ANAli Reza Naseri
Ali Reza Naseri
MMMohammad Mohammadzadeh
Mohammad Mohammadzadeh
MSMohammad Hossein Somi
Mohammad Hossein Somi
Impact of Tumor Length on Survival for Patients with Resected Esophageal Cancer Survival;esophageal cancer;tumor length;ROC curve;postoperative chemo radiotherapy;Iran; Background: Tumor length in patients with esophageal cancer (EC) has recently received great attention. However, its prognostic role for EC is controversial. The purpose of our study was to characterize the prognostic value of tumor length in EC patients and offer the optimum cut-off point of tumor length by reliable statistical methods. Materials and Methods: A retrospective analysis was conducted on 71 consecutive patients with EC who underwent surgery. ROC curve analysis was used to determine the optimal cut-off point for tumor length, measured with a handheld ruler after formalin fixation. Correlations between tumor length and other factors were surveyed, and overall survival (OS) rates were compared between the two groups. Potential prognostic factors were evaluated by univariate Kaplan-Meier survival analysis. A P value less than 0.05 was considered significant. Results: There were a total of 71 patients, with a male/female divide of 43/28 and a median age of 59. Characteristics were as follows: squamous/adenocarcinoma, 65/6; median tumor length, 4 (0.9-10); cut-off point for tumor length, 4cm. Univariate analysis prognostic factors were tumor length and modality of therapy. One, three and five year OS rates were 84, 43 and 43% for tumors with ${\leq}4cm$ length, whereas the rates were 75, 9 and 0% for tumors >4 cm. There was a significant association between tumor length and age, sex, weight loss, tumor site, histology, T and N scores, differentiation, stage, modality of therapy and longitudinal margin involvement. Conclusions: Future studies for modification of the EC staging system might consider tumor length too as it is an important prognostic factor. Further assessment with larger prospective datasets and practical methods (such as endoscopy) is needed to establish an optimal cut-off point for tumor length.

1 January 2018
Verified
Journal Article
Open access
PDF file
SMSeyed Kazem Mirinezhad
Seyed Kazem Mirinezhad
FMFarideh Mousavi
Farideh Mousavi
MBMasood Bagheri
Masood Bagheri
BSBita Sepehri
Bita Sepehri
AGAli Ghavidel
Ali Ghavidel
MSMohammad Hossin Somi
Mohammad Hossin Somi
Objective: Familial adenomatous polyposis (FAP), an autosomal dominant inherited disorder is characterized by the presence of multiple adenomatous colorectal polyps, which can develop into cancer during early adulthood. Therefore, early diagnosis is essential. Most FAP patients have several extracolonic manifestations, including congenital hypertrophy of the retinal pigment epithelium (CHRPE). Whereas genetic markers may provide the main route to detection of ‘‘at risk’’ subjects , at present this approach is clearly limited and searches for a noninvasive phenotypic marker continue to be high priority.The aim of this study was to describe the pattern of distribution of CHRPE lesions and evaluate their diagnostic value in FAP patients and their family members in a local population. Methods: A total of 23 FAP patients and 26 relatives belonging to 12 families at high risk of developing FAP were subjected to colonoscopic and ophthalmological examination. Result: Retinal examinations demonstrated prevalences of CHRPE in FAP patents and their siblings of 78% and 38%, respectively. We were able to illustrate a significant correlation between FAP disease and the presence of retinal lesions. Sensitivity and specificity of CHRPE as a screening test to detect the presence of FAP are 78.3% and 61.5%, respectively, with a positive predictive value of 64.3% and a negative predictive value of 76.2 %. A "lesion form" significant difference was found between FAP and normal participants.Spearman nonparametric analysis revealed no correlation between age and number or size of lesions. Conclusion: Multiple CHRPE lesions are a diagnostic feature of FAP patients They are specific and sensitive clinical markers of this disease (specificity 60% and sensitivity 77%).

30 March 2013 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SMSeyed Kazem Mirinezhad
Seyed Kazem Mirinezhad
MSMohammad Hossein Somi
Mohammad Hossein Somi
FSFarshad Seyednezhad
Farshad Seyednezhad
AJAmir Ghasemi Jangjoo
Amir Ghasemi Jangjoo
MGMorteza Ghojazadeh
Morteza Ghojazadeh
BNBehnam Nasiri
Behnam Nasiri
Areas of Iran have among the highest incidences of esophageal cancer in the world. Definitive chemo-radiotherapy (DCRT) is used for locally advanced esophageal cancer and for inoperable tumors asan alternative to surgical treatment.

1 January 2019 in Journal of Cancer Research and Therapeutics
Verified
Journal Article
Closed access
MSMohammadHossein Somi
MohammadHossein Somi
SMSeyedKazem Mirinezhad
SeyedKazem Mirinezhad
SMSeyedYaqoob Moaddab
SeyedYaqoob Moaddab
MBMortazaJ Bonyadi
MortazaJ Bonyadi
MSMasoud Shirmohammadi
Masoud Shirmohammadi
AEAmirTaher Eftekharsadat
AmirTaher Eftekharsadat
Context: Familial adenomatous polyposis (FAP) is an autosomal dominant disorder. Colorectal cancer (CRC) has been implicated as the most common cause of death in FAP patients, especially in those with coexisting CRC at initial diagnosis (FAP-CRC). Aim: We aimed to determine the survival rate of FAP-CRC and the factors affecting FAP-CRC survival. Setting and Design: This was a retrospective cohort FAP study conducted in northwest Iran. Subjects and Methods: From 2006 to 2016, 51 FAP-CRC individuals were selected from among 4588 CRC patients. Statistical Analysis: A Student's t-test, life table method, log-rank tests, a Kaplan–Maier survival curve, and Cox regression analysis were performed and a value of P < 0.05 was set as statistically significant. Results: A total of 51 FAP-CRC patients were selected, (30 males and 21 females), with a mean age of 42.2 years at diagnosis. The most common presenting symptom was abdominal pain and the most common primary tumor site was the rectum. The 1-, 5- and 10-year overall survival rates were 76%, 59%, and 52%, respectively. Factors affecting the FAP-CRC survival rate, namely, sex, age at CRC diagnosis, and extracolonic manifestations showed no significant differences. The difference in 5-year survival rates between patients with colon and rectal cancers was significant (75% vs. 33%, P < 0.02). The survival rate was significantly higher among patients with disease Stages I and II than those in disease Stages III and IV (P < 0.001). 5-year survival rates in patients with ileal pouch-anal anastomosis and ileorectal anastomosis were 71% and 78%, respectively (P < 0.001). There was an interesting difference in survival between FAP and attenuated FAP (P < 0.01). In cox regression analysis, distant metastasis was a significant predictor of survival (P < 0.001). Conclusions: Long-term survival from FAP-CRC remains poor; therefore, early-stage detection and the choice of an appropriate surgical method can improve survival in such patients.